Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesReceivablesReceivables - AccuredRetained EarningsSecurities - Mortgage Backed SecuritiesSecurities - TradableShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Global Indemnity (GBLI) Cash & Equivalents (2016 - 2025)

Global Indemnity has reported Cash & Equivalents over the past 16 years, most recently at $75.4 million for Q3 2025.

  • Quarterly results put Cash & Equivalents at $75.4 million for Q3 2025, up 142.95% from a year ago — trailing twelve months through Sep 2025 was $75.4 million (up 142.95% YoY), and the annual figure for FY2024 was $17.0 million, down 55.28%.
  • Cash & Equivalents for Q3 2025 was $75.4 million at Global Indemnity, up from $67.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for GBLI hit a ceiling of $157.9 million in Q1 2022 and a floor of $17.0 million in Q4 2024.
  • Median Cash & Equivalents over the past 5 years was $46.5 million (2023), compared with a mean of $53.4 million.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 232.66% in 2022 and later plummeted 77.37% in 2023.
  • Global Indemnity's Cash & Equivalents stood at $78.3 million in 2021, then plummeted by 50.37% to $38.8 million in 2022, then fell by 2.08% to $38.0 million in 2023, then plummeted by 55.28% to $17.0 million in 2024, then soared by 343.06% to $75.4 million in 2025.
  • The last three reported values for Cash & Equivalents were $75.4 million (Q3 2025), $67.3 million (Q2 2025), and $81.1 million (Q1 2025) per Business Quant data.